虫草素
前药
化学
腺苷脱氨酶
脱氧腺苷
脱氨基
腺苷脱氨酶抑制剂
氨基
脱氧甲氧霉素
核苷
腺苷
体外
生物化学
嘌呤核苷磷酸化酶
胸腺嘧啶
药理学
立体化学
酶
嘌呤
DNA
生物
作者
Hui‐Min Chang,J. Oakes,Anders Olsson,Luminita Panaitescu,Blair C. Britt,Christopher M. Kearney,Robert R. Kane
出处
期刊:Letters in Drug Design & Discovery
[Bentham Science]
日期:2005-03-01
卷期号:2 (2): 133-136
被引量:9
标识
DOI:10.2174/1570180053175151
摘要
Cordycepin (3;-deoxyadenosine) is a potent anti-leukemic, anti-fungal, and anti-parasitic nucleoside antibiotic. Unfortunately, the biological activity of cordycepin is attenuated by its rapid conversion to 3;-deoxyinosine by adenosine deaminase (ADA). We have synthesized a series of ADA-resistant N-aminal and N-thioaminal cordycepin derivatives, which are protected from inactivation by deamination and yet retain biological activity. These compounds are hydrolyzed at various rates to efficiently release the parent drug cordycepin, and likely serve as simple hydrolytically activated prodrugs. Keywords: cordycepin, adenosine deaminase, leukemia, prodrug
科研通智能强力驱动
Strongly Powered by AbleSci AI